Skip to main content

Table 2 Assessment of prisoner HCV treatment need and policy determining care in 5 European countries

From: Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe

 

Country

Spaina

England & Wales

France

Italy

Germany

Population

 Total prisoners (‘000 s)

60 [76, 77]

86 [78]

79 [79]

56 [80]

64 [81]

 Prisoners requiring HCV treatment (‘000 s)b

6

9

8

6

6

 Prisoners, custody sufficient for treatment ‘000 s, (%)

4 (70) [82]

5 (60) [78]

4 (50) [79]

3 (50) [83]

3 (50) [81]

Policy

 Law defines equivalence of prison healthcare (Year introduced)

1996 [26]

2003 [27]

1994 [28]

1998 [29]

2009 [30]

 HCV plan includes prisoners

Harm reduction; HCV Screening, Prevention & Diagnosis in prison [31]

Increase uptake & accessibility to HCV testing & treatment [32]

Harm reduction; Screening; DAA treatment; medical/ social coverage on release [33]

No HCV plan identified

Improve prevention, diagnosis and treatment of HCV [84]

 Prison health plan includes HCV

Access to NEP; repeated HCV screening (inc pre-trial); HCV treatment; in situ specialist; continuity of care [40]

HCV testing on entry, during imprisonment; results provided to community-based GP, if consented [85]

Access to screening readily on entry & continuity of care [36]

Multidisciplinary team to promote awareness and provide support for HCV-infected inmates [38]

No prison health plan identified

 Prisoner HCV clinical practice guidelines

All inmates offered HCV RNA test, liver biopsies without delay [41]

Access to opt-out DBS testing; in situ BBV specialist; referral & treatment via integrated care team [35]

Recommended annual HCV screening; access to DAA treatment with continuity on release/ transfer [86]

Increase HCV awareness & risk behaviour; access to screening & treatment [87]

No prisoner HCV clinical practice guidelines identified

Practice

 Access to treatment

Widespread

Increasing but limited in some areas

Increasing but limited in some areas

Increasing but limited in some areas

Limited

Governance

 Organization responsible for prison healthcare

Ministry of Interior

Ministry of Health

Ministry of Health

Ministry of Health

Ministry of Justice

 Level of decision making

Regional

National

National

National

Regional

 Funding

Ministry of Justice

NHS

NHS

NHS

16 Ministries of Justice

  1. This table provides an estimate of the number of prisoners requiring treatment for HCV infection in 5 European countries and a description of the policy and governance which defines the approach to prisoner HCV care
  2. aSpain has 2 Penitentiary Administrations: the Penitentiary Administration of Catalonia and the Penitentiary Administration of the rest of Spain. The data presented is the sum of those of both Administrations
  3. bPrisoner HCV population was estimated based on published data sources and experience of experts; the range of data points retrieved from published sources is quoted in brackets for reference